These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14106882)

  • 1. COMPARISON OF THE BLOOD LEVELS OBTAINED AFTER SINGLE AND MULTIPLE DOSES OF ERYTHROMYCIN ESTOLATE AND ERYTHROMYCIN STEARATE.
    GRIFFITH RS; BLACK HR
    Am J Med Sci; 1964 Jan; 247():69-74. PubMed ID: 14106882
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate.
    Welling PG; Elliott RL; Pitterle ME; Corrick-West HP; Lyons LL
    J Pharm Sci; 1979 Feb; 68(2):150-5. PubMed ID: 423080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin jaundice: diagnosis by an in vitro challenge test.
    Cooksley WG; Powell LW
    Aust N Z J Med; 1977 Jun; 7(3):291-3. PubMed ID: 269690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.
    Croteau D; Bergeron MG; LeBel M
    Antimicrob Agents Chemother; 1988 Apr; 32(4):561-5. PubMed ID: 3259856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of erythromycin in serum and tonsil: comparison of the estolate and ethyl succinate suspensions.
    Ginsburg CM; McCracken GH; Culbertson MC
    J Pediatr; 1976 Dec; 89(6):1011-3. PubMed ID: 792404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythromycin estolate and jaundice.
    Inman WH; Rawson NS
    Br Med J (Clin Res Ed); 1983 Jun; 286(6382):1954-5. PubMed ID: 6407653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of blood levels after oral administration of erythromycin and erythromycin estolate.
    GRIFFITH RS; BLACK HR
    Antibiot Chemother (Northfield); 1962 Jun; 12():398-403. PubMed ID: 13901859
    [No Abstract]   [Full Text] [Related]  

  • 8. A simple thin-layer chromatographic identification procedure for erythromycin base, stearate, estolate and ethylsuccinate.
    Vilim A; LeBelle MJ; Wilson WL; Graham KC
    J Chromatogr; 1977 Mar; 133(1):239-44. PubMed ID: 838805
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state].
    Potthast H; Schug B; Elze M; Schwerdtle R; Blume H
    Pharmazie; 1995 Jan; 50(1):56-60. PubMed ID: 7886126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of erythromycin base and estolate in gonococcal urethritis.
    Brown ST; Pedersen HB; Holmes KK
    JAMA; 1977 Sep; 238(13):1371-3. PubMed ID: 408522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of an oral erythromycin product.
    Fraser DG
    Am J Hosp Pharm; 1980 Sep; 37(9):1199-205. PubMed ID: 6998290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA begins proceedings to remove erythromycin estolate from market.
    FDA Drug Bull; 1979 Nov; 9(5):26-7. PubMed ID: 510836
    [No Abstract]   [Full Text] [Related]  

  • 13. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.
    Langley JM; Halperin SA; Boucher FD; Smith B;
    Pediatrics; 2004 Jul; 114(1):e96-101. PubMed ID: 15231980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin estolate to remain on market.
    FDA Drug Bull; 1982 Aug; 12(2):14. PubMed ID: 7141171
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythromycin propionate and estolate.
    Farre M
    Lancet; 1988 Jul; 2(8601):45. PubMed ID: 2898648
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection.
    Halperin SA; Bortolussi R; Langley JM; Eastwood BJ; De Serres G
    Pediatrics; 1999 Oct; 104(4):e42. PubMed ID: 10506267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STUDIES OF PREMATURES GIVEN ERYTHROMYCIN ESTOLATE.
    BURNS L; HODGMAN J
    Am J Dis Child; 1963 Sep; 106():280-8. PubMed ID: 14057607
    [No Abstract]   [Full Text] [Related]  

  • 18. Variability in the absorption and disposition of erythromycin estolate in humans.
    Stubbs C; Kanfer I
    J Pharm Sci; 1989 Aug; 78(8):635-8. PubMed ID: 2778669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythromycin therapy for group A streptococcal pharyngitis. Results of a comparative study of the estolate and ethylsuccinate formulations.
    Ginsburg CM; McCracken GH; Crow SD; Dildy BR; Morchower G; Steinberg JB; Lancaster K
    Am J Dis Child; 1984 Jun; 138(6):536-9. PubMed ID: 6372437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-benefit equation for erythromycin estolate.
    LeBel M
    Am J Hosp Pharm; 1980 Feb; 37(2):176, 180. PubMed ID: 7361788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.